BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2692641)

  • 21. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin receptors--where are they going?
    Leonard BE
    Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():7-17. PubMed ID: 8021439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Hydroxytryptamine in the central nervous system.
    Chojnacka-Wójcik E
    Pol J Pharmacol; 1995; 47(3):219-35. PubMed ID: 8714755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of food intake by manipulation of central serotonin. Current experimental results.
    Garattini S; Mennini T; Samanin R
    Br J Psychiatry Suppl; 1989 Dec; (8):41-51. PubMed ID: 2692639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [5HT-moduline an new peptide specifically interactive with the serotonergic system: physiopathologic implications].
    Fillion G
    Ann Pharm Fr; 1998; 56(4):145-7. PubMed ID: 9770005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach.
    Paul D; Yao D; Zhu P; Minor LD; Garcia MM
    J Pharmacol Exp Ther; 2001 Aug; 298(2):674-8. PubMed ID: 11454930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine].
    Martin P; Lemonnier F
    Encephale; 1994; 20(4):427-35. PubMed ID: 7988407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
    Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
    Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of serotonin in depression and anxiety.
    Baldwin D; Rudge S
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():41-5. PubMed ID: 7622823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability in the effects of 5-HT-related compounds in experimental models of anxiety: evidence for multiple mechanisms of 5-HT in anxiety or never ending story?
    Griebel G
    Pol J Pharmacol; 1996; 48(2):129-36. PubMed ID: 9112642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin receptor physiology: relation to emesis.
    Hasler WL
    Dig Dis Sci; 1999 Aug; 44(8 Suppl):108S-113S. PubMed ID: 10490049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New therapeutic possibilities with drugs affecting serotonin receptors].
    Spigset O
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple serotonin receptors: clinical and experimental aspects.
    Roth BL
    Ann Clin Psychiatry; 1994 Jun; 6(2):67-78. PubMed ID: 7804391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.